Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease.

Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol (2007) 3.96

Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol (2009) 3.09

C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study. Circ Cardiovasc Qual Outcomes (2008) 2.50

High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH. J Gastroenterol (2007) 2.29

Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery. J Vasc Surg (2006) 2.14

Lower extremity peripheral artery disease in the absence of traditional risk factors. The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis (2010) 1.71

Inflammation and cardiovascular events in individuals with and without chronic kidney disease. Kidney Int (2008) 1.64

Pneumococcal vaccination and risk of myocardial infarction. CMAJ (2008) 1.61

Inflammation, coronary artery calcification and cardiovascular events in incident renal transplant recipients. Atherosclerosis (2010) 1.60

Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag (2009) 1.59

Peripheral artery disease: current insight into the disease and its diagnosis and management. Mayo Clin Proc (2010) 1.58

Epidemiology, classification, and modifiable risk factors of peripheral arterial disease. Vasc Health Risk Manag (2007) 1.51

Biomarkers of Inflammation and MRI-Defined Small Vessel Disease of the Brain: The Cardiovascular Health Study. Stroke (2008) 1.48

Interpretation of observational studies. Heart (2004) 1.46

TST, as a polysomnographic variable, is superior to the apnea hypopnea index for evaluating intermittent hypoxia in severe obstructive sleep apnea. Eur Arch Otorhinolaryngol (2014) 1.42

Dyslipidemic drugs in metabolic syndrome. Indian J Endocrinol Metab (2013) 1.39

Sex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease: the Mayo Clinic proteomic markers of arteriosclerosis study. PLoS One (2010) 1.34

Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis. Dig Dis Sci (2011) 1.29

Exercise rehabilitation in peripheral artery disease: functional impact and mechanisms of benefits. Circulation (2011) 1.27

Biomarkers of obesity and subsequent cardiovascular events. Epidemiol Rev (2007) 1.17

Evaluation of different formulas for LDL-C calculation. Lipids Health Dis (2010) 1.17

Socioeconomic status gradients in inflammation in adolescence. Psychosom Med (2013) 1.15

Inflammatory concepts of obesity. Int J Inflam (2011) 1.14

High interleukin-6 plasma levels are associated with low HDL-C levels in community-dwelling older adults: the InChianti study. Atherosclerosis (2006) 1.13

Cross-sectional relations of multiple inflammatory biomarkers to peripheral arterial disease: The Framingham Offspring Study. Atherosclerosis (2008) 1.08

Lipoprotein(a) and risk of coronary, cerebrovascular, and peripheral artery disease: the EPIC-Norfolk prospective population study. Arterioscler Thromb Vasc Biol (2012) 1.04

Ezetimibe reduces plaque inflammation in a rabbit model of atherosclerosis and inhibits monocyte migration in addition to its lipid-lowering effect. Br J Pharmacol (2009) 1.04

Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction. Heart Fail Rev (2003) 1.03

Sex/gender medicine. The biological basis for personalized care in cardiovascular medicine. Circ J (2009) 1.01

High-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazone. J Diabetes Sci Technol (2010) 1.00

Genome-wide association studies of coronary artery disease and heart failure: where are we going? Pharmacogenomics (2009) 1.00

Analysis of arterial intimal hyperplasia: review and hypothesis. Theor Biol Med Model (2007) 0.98

Noninvasive assessment of preclinical atherosclerosis. Vasc Health Risk Manag (2006) 0.97

Does LDL-C Estimation Using Anandaraja's Formula Give a Better Agreement with Direct LDL-C Estimation than the Friedewald's Formula? Indian J Clin Biochem (2012) 0.96

Oxidation-specific biomarkers and risk of peripheral artery disease. J Am Coll Cardiol (2013) 0.96

Role of surrogate markers of atherosclerosis in clinical and subclinical thyroidism. Int J Endocrinol (2012) 0.95

CRP enhances soluble LOX-1 release from macrophages by activating TNF-α converting enzyme. J Lipid Res (2011) 0.95

Risk factors for age-related maculopathy. J Ophthalmol (2009) 0.95

Circulating blood markers and functional impairment in peripheral arterial disease. J Am Geriatr Soc (2008) 0.94

Obese reproductive-age women exhibit a proatherogenic inflammatory response during hyperglycemia. Obesity (Silver Spring) (2007) 0.93

Increased levels of the calcification marker matrix Gla Protein and the inflammatory markers YKL-40 and CRP in patients with type 2 diabetes and ischemic heart disease. Cardiovasc Diabetol (2010) 0.91

Ischemia-modified albumin in type 2 diabetic patients with and without peripheral arterial disease. Clinics (Sao Paulo) (2011) 0.91

Associations of candidate biomarkers of vascular disease with the ankle-brachial index and peripheral arterial disease. Am J Hypertens (2013) 0.90

Plasma homocysteine, dietary B vitamins, betaine, and choline and risk of peripheral artery disease. Atherosclerosis (2014) 0.90

Gluten-free vegan diet induces decreased LDL and oxidized LDL levels and raised atheroprotective natural antibodies against phosphorylcholine in patients with rheumatoid arthritis: a randomized study. Arthritis Res Ther (2008) 0.90

hs-CRP: A potential marker for hypertension in Kashmiri population. Indian J Clin Biochem (2010) 0.89

n-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial. Vasc Med (2013) 0.89

NT-proBNP, C-reactive protein and soluble uPAR in a bi-ethnic male population: the SAfrEIC study. PLoS One (2013) 0.89

Inflammation, haemostatic disturbance, and obesity: possible link to pathogenesis of diabetic retinopathy in type 2 diabetes. Mediators Inflamm (2013) 0.89

Risk factors for incident peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation in type 2 Diabetes (BARI 2D) Trial. Diabetes Care (2014) 0.88

Effect of psyllium fiber supplementation on C-reactive protein: the trial to reduce inflammatory markers (TRIM). Ann Fam Med (2008) 0.88

ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease): developed in collaboration with the American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabilitation; American College of Preventive Medicine; American College of Sports Medicine; American Diabetes Association; American Society of Hypertension; Association of Black Cardiologists; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute; National Lipid Association; and Preventive Cardiovascular Nurses Association. J Am Coll Cardiol (2009) 0.88

Beneficial effects of cardiac rehabilitation and exercise after percutaneous coronary intervention on hsCRP and inflammatory cytokines in CAD patients. Pflugers Arch (2007) 0.88

Effect of intensive non-surgical treatment on the level of serum inflammatory markers in advanced periodontitis. J Dent (Tehran) (2010) 0.87

Lipoprotein (a) concentrations, apolipoprotein (a) phenotypes, and peripheral arterial disease in three independent cohorts. Cardiovasc Res (2014) 0.87

Niacin inhibits vascular inflammation via downregulating nuclear transcription factor-κB signaling pathway. Mediators Inflamm (2014) 0.87

Criticial limb ischemia: epidemiology. Methodist Debakey Cardiovasc J (2013) 0.87

Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study. Vasc Med (2013) 0.86

Optimal management of infrainguinal arterial occlusive disease. Vasc Health Risk Manag (2014) 0.86

Lipoprotein(a), inflammation, and peripheral arterial disease in a community-based sample of older men and women (the InCHIANTI study). Am J Cardiol (2010) 0.86

Changes in A1C levels are significantly associated with changes in levels of the cardiovascular risk biomarker hs-CRP: results from the SteP study. Diabetes Care (2013) 0.86

Plasma proprotein convertase subtilisin/kexin type 9 levels and the risk of first cardiovascular events. Eur Heart J (2015) 0.86

Metabolic syndrome and risk of incident peripheral artery disease: the cardiovascular health study. Hypertension (2013) 0.85

Effects of periodontal therapy on C-reactive protein and HDL in serum of subjects with periodontitis. Rev Bras Cir Cardiovasc (2014) 0.85

Genetic polymorphisms in homocysteine metabolism and response to folate intake: a comprehensive strategy to elucidate useful genetic information. J Epidemiol (2010) 0.85

Cholesterol ester transfer protein (CETP) gene polymorphism and selected parameters of lipid metabolism in children from families with history of cardiovascular system diseases. Med Sci Monit (2013) 0.85

Sex difference in the association of metabolic syndrome with high sensitivity C-reactive protein in a Taiwanese population. BMC Public Health (2010) 0.85

Activation of monocytes and cytokine production in patients with peripheral atherosclerosis obliterans. J Inflamm (Lond) (2011) 0.85

Short-Term, High-Dose Fish Oil Supplementation Increases the Production of Omega-3 Fatty Acid-Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA-PAD I Trial). J Am Heart Assoc (2015) 0.85

Lipoprotein (a) measurements for clinical application. J Lipid Res (2015) 0.84

Leukotrienes as modifiers of preclinical atherosclerosis? ScientificWorldJournal (2012) 0.84

Association between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease. J Vasc Surg (2013) 0.84

Diagnosis and management of peripheral artery disease in women. Int J Womens Health (2012) 0.83

Differences in responses of platelets to fluid shear stress in patients with peripheral artery disease (PAD) and coronary artery disease (CAD). Platelets (2009) 0.83

Association of monocyte tumor necrosis factor α expression and serum inflammatory biomarkers with walking impairment in peripheral artery disease. J Vasc Surg (2014) 0.83

New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor. Clin Interv Aging (2008) 0.83

Modulation of circulating macrophage migration inhibitory factor in the elderly. Biomed Res Int (2014) 0.83

A review of the pathophysiology and potential biomarkers for peripheral artery disease. Int J Mol Sci (2015) 0.83

Increased prevalence of peripheral arterial disease in osteoporotic postmenopausal women. J Bone Miner Metab (2006) 0.82

Prediction of stroke in the general population in Europe (EUROSTROKE): Is there a role for fibrinogen and electrocardiography? J Epidemiol Community Health (2002) 0.82

Retinal emboli and cardiovascular disease: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc (2003) 0.82

Relation between Body Iron Status and Cardiovascular Risk Factors in Patients with Cardiovascular Disease. Int J Prev Med (2013) 0.82

Gender-specific risk factors for peripheral artery disease in a voluntary screening population. J Am Heart Assoc (2014) 0.82

Plasma levels of the proinflammatory chitin-binding glycoprotein YKL-40, variation in the chitinase 3-like 1 gene (CHI3L1), and incident cardiovascular events. J Am Heart Assoc (2014) 0.81

The level of hs-CRP in coronary artery ectasia and its response to statin and angiotensin-converting enzyme inhibitor treatment. Mediators Inflamm (2006) 0.81

Relationship of microparticles to progenitor cells as a measure of vascular health in a diabetic population. Cytometry B Clin Cytom (2010) 0.81

C-reactive protein in adolescent twins: patterns and relationship to adiposity. J Clin Endocrinol Metab (2011) 0.81

Novel markers of peripheral arterial disease. Vasc Med (2009) 0.81

Biomarkers of chronic inflammatory state in uremia and cardiovascular disease. Int J Inflam (2012) 0.81

Premature peripheral arterial disease - difficult diagnosis in very early presentation. Int J Angiol (2009) 0.81

The role of inflammation in cardiovascular diseases: the predictive value of neutrophil-lymphocyte ratio as a marker in peripheral arterial disease. Ther Clin Risk Manag (2016) 0.80

Screening for subclinical atherosclerosis by noninvasive methods in asymptomatic patients with risk factors. Clin Interv Aging (2013) 0.80

Preoperative C-reactive protein predicts long-term mortality and hospital length of stay after primary, nonemergent coronary artery bypass grafting. Anesthesiology (2010) 0.80

High-sensitivity C-reactive protein can predict major adverse cardiovascular events in Korean patients with type 2 diabetes. J Korean Med Sci (2011) 0.80

White blood cell count predicts all-cause mortality in patients with suspected peripheral arterial disease. Am J Med (2009) 0.80

Relationship of impairment induced by intracellular S-adenosylhomocysteine accumulation with DNA methylation in human umbilical vein endothelial cells treated with 3-deazaadenosine. Int J Exp Pathol (2009) 0.80

Low levels of IgM antibodies to oxidized cardiolipin increase and high levels decrease risk of cardiovascular disease among 60-year olds: a prospective study. BMC Cardiovasc Disord (2013) 0.80

High-sensitivity C-reactive protein and ankle brachial index in a finnish cardiovascular risk population. Int J Angiol (2011) 0.79

C-reactive protein is elevated in the offspring of parents with essential hypertension. Arch Dis Child (2006) 0.79

Association of blood lipids, creatinine, albumin, and CRP with socioeconomic status in Malawi. Popul Health Metr (2013) 0.79

Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol (1985) 26.13

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med (1997) 18.85

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med (2000) 18.04

Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol (1992) 17.17

Total energy intake: implications for epidemiologic analyses. Am J Epidemiol (1986) 16.34

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA (2001) 15.85

Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med (2001) 14.48

The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med (1995) 11.08

Body weight and mortality among women. N Engl J Med (1995) 11.04

Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol (1989) 10.98

Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol (1986) 10.84

Validity of self-reported waist and hip circumferences in men and women. Epidemiology (1990) 10.57

Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol (1994) 9.90

Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc (1993) 9.90

Aspirin and the risk of colorectal cancer in women. N Engl J Med (1995) 9.59

Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol (1999) 9.34

Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J (1985) 9.28

Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med (1990) 8.98

Prospective study of alcohol consumption and risk of coronary disease in men. Lancet (1991) 8.64

A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA (1995) 8.60

Test of the National Death Index. Am J Epidemiol (1984) 8.46

Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med (1997) 8.43

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation (2000) 8.17

Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet (1991) 7.87

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med (2001) 7.51

Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care (1994) 7.11

Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA (1998) 7.09

Reproducibility and validity of dietary patterns assessed with a food-frequency questionnaire. Am J Clin Nutr (1999) 7.02

Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA (1997) 6.92

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science (1998) 6.50

Test of the National Death Index and Equifax Nationwide Death Search. Am J Epidemiol (1994) 6.47

The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med (2001) 6.37

Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med (1993) 6.37

Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men. Arch Intern Med (2001) 6.23

Abdominal adiposity and coronary heart disease in women. JAMA (1998) 6.21

Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med (1999) 6.17

A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med (1990) 6.06

A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med (1993) 5.87

Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk. Am J Clin Nutr (2001) 5.67

The assessment of alcohol consumption by a simple self-administered questionnaire. Am J Epidemiol (1991) 5.60

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA (2001) 5.54

Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med (1995) 5.42

Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med (1994) 5.42

The use of a self-administered questionnaire to assess diet four years in the past. Am J Epidemiol (1988) 5.32

Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study. JAMA (1993) 5.31

Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst (1999) 5.27

A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med (2000) 5.17

Prospective study of major dietary patterns and risk of coronary heart disease in men. Am J Clin Nutr (2000) 5.17

A prospective cohort study of vasectomy and prostate cancer in US men. JAMA (1993) 5.09

Intake of trans fatty acids and risk of coronary heart disease among women. Lancet (1993) 5.00

Postmenopausal hormone therapy and mortality. N Engl J Med (1997) 4.96

A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med (1995) 4.94

Dual effects of weight and weight gain on breast cancer risk. JAMA (1997) 4.81

Dietary fat and fiber in relation to risk of breast cancer. An 8-year follow-up. JAMA (1992) 4.80

Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range. JAMA (1995) 4.78

Menopause and the risk of coronary heart disease in women. N Engl J Med (1987) 4.70

Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst (1996) 4.66

Weight as a risk factor for clinical diabetes in women. Am J Epidemiol (1990) 4.64

A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women. N Engl J Med (1999) 4.61

A prospective study of passive smoking and coronary heart disease. Circulation (1997) 4.51

A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA (1997) 4.50

Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976. BMJ (1997) 4.49

Birthweight and the risk for type 2 diabetes mellitus in adult women. Ann Intern Med (1999) 4.49

Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care (1997) 4.46

Cigarette smoking, relative weight, and menopause. Am J Epidemiol (1983) 4.46

A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. Am J Clin Nutr (2000) 4.38

Reproducibility and validity of a self-administered physical activity questionnaire for male health professionals. Epidemiology (1996) 4.37

Smoking cessation and decreased risk of stroke in women. JAMA (1993) 4.36

Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA (2001) 4.30

Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA (1996) 4.29

PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet (1997) 4.27

Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr (2001) 4.26

Alcohol consumption and mortality among women. N Engl J Med (1995) 4.22

Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits. BMJ (1996) 4.21

Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med (1997) 4.16

Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ (1999) 4.14

Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl J Med (1995) 4.06

Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet (1998) 3.97

Physical activity and risk of stroke in women. JAMA (2000) 3.95

Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women. Am J Clin Nutr (1999) 3.91

Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation (1999) 3.90

Whole-grain consumption and risk of coronary heart disease: results from the Nurses' Health Study. Am J Clin Nutr (1999) 3.89

Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med (1995) 3.88

Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst (1995) 3.88

Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA (1994) 3.86

A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med (1991) 3.85

Recreational physical activity and the risk of cholecystectomy in women. N Engl J Med (1999) 3.82

Reproducibility and validity of self-reported menopausal status in a prospective cohort study. Am J Epidemiol (1987) 3.77

Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol (1995) 3.76

Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med (1998) 3.73

The validity of recalled weight among younger women. Int J Obes Relat Metab Disord (1995) 3.68

A prospective study of aspirin use and primary prevention of cardiovascular disease in women. JAMA (1991) 3.67

Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation (2000) 3.66

Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA (2001) 3.59

Dietary patterns and the risk of coronary heart disease in women. Arch Intern Med (2001) 3.59

Body weight, weight change, and risk for hypertension in women. Ann Intern Med (1998) 3.56

A prospective study of nutritional factors and hypertension among US men. Circulation (1992) 3.51

A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst (1993) 3.40

Birth weight and adult hypertension, diabetes mellitus, and obesity in US men. Circulation (1996) 3.40